Barth syndrome (BTHS) is an inherited form of cardiomyopathy, caused by a mutation within the gene encoding the mitochondrial transacylase tafazzin. Tafazzin is involved in the biosynthesis of the unique phospholipid cardiolipin (CL), which is almost exclusively found in mitochondrial membranes. CL directly interacts with a number of essential protein complexes in the mitochondrial membranes including the respiratory chain, mitochondrial metabolite carriers, and proteins, involved in shaping mitochondrial morphology. Here we describe, how in BTHS CL deficiency causes changes in the morphology of mitochondria, structural changes in the respiratory chain, decreased respiration, and increased generation of reactive oxygen species. A large number of cellular and animal models for BTHS have been established to elucidate how mitochondrial dysfunction induces sarcomere disorganization and reduced contractility, resulting in dilated cardiomyopathy in vivo.
Introduction
Barth syndrome (BTHS) is an x-linked autosomal recessive disease characterized by cardiomyopathy, skeletal myopathy, neutropenia, growth retardation, and 3-methylglutaconic acidurea. BTHS patients have a high rate of mortality throughout infancy, which is primarily related to progressive cardiomyopathy and a severely weakened immune system. BTHS occurs at an estimated frequency of about 1 case per 300 000 to 400 000 births, and there are also reports on a substantial risk of foetal loss and stillbirths.
1,2 BTHS was first described by Peter Barth in 1983. 3 In 1996 the causative mutation for BTHS was found in the gene encoding tafazzin (TAZ) in the distal region of chromosome Xq28. 4 ,5 Subsequent analysis of the gene locus led to the identification of a large number of patients affected by the disease. 1, [5] [6] [7] [8] The enzymatic function of tafazzin, encoded by the TAZ gene was identified in 2006 as a mitochondrial acyltransferase, involved in the biogenesis of cardiolipin (CL), a phospholipid, almost exclusively found in mitochondrial membranes. 9 Our understanding of BTHS has accelerated after a mouse model was developed by two groups in 2011. 10, 11 Mitochondria are the primary source of the energy in cardiac tissue as they provide 90% of 6 kg of adenosine triphosphate (ATP) turned over in 1 day by an adult human heart. To meet this energy demand, cardiac muscle has a very high mitochondrial density, occupying 35% of the cardiomyocyte volume. 12 ATP is generated through oxidative phosphorylation, with the Krebs cycle products NADH and FADH 2 delivering electrons to complexes I and II of the respiratory chain, respectively. To match the ATP supply to the constantly varying demand, the most important regulators are ADP and Ca 2þ , where ADP accelerates ATP production at the F 1 F o -ATP synthase and thereby, electron flux along the respiratory chain ( Figure 1 ). To prevent depletion of pyridine nucleotides, Ca 2þ is taken up by the mitochondrial Ca 2þ uniporter and stimulates key dehydrogenases of the Krebs cycle, accelerating the regeneration of NADH and FADH 2 . 13 During oxidative phosphorylation, physiological amounts of reactive oxygen species (ROS) are generated at the ETC which are eliminated by the anti-oxidative capacity in the mitochondrial matrix. 14 
. Since NADPH is regenerated by enzymes that derive their substrates from the Krebs cycle, mitochondrial Ca 2þ uptake is not only important to match ATP supply to demand at the respiratory chain, but also to keep the anti-oxidative capacity in a reduced state to prevent the excessive emission of ROS from mitochondria. 14 Besides ATP and ROS production, mitochondria are involved in the metabolism of amino acids and lipids and are required for the biogenesis of haeme and iron-sulfur clusters. Mitochondria possess two highly specialized membranes, the outer-(OMM) and the inner mitochondrial membrane (IMM), and separating
the two membranes is the intermembrane space (IMS). The OMM plays a role in connecting the mitochondrion to different organelles in the cell, including the (sarco-) endoplasmic reticulum (SR/ER), the lysosome, and the plasma membrane. [15] [16] [17] [18] The IMM forms two separate structures, the inner boundary membrane in close opposition to the outer membrane, and the cristae structures, which are invaginations into the matrix compartment. Cristae structures are crucial for the energy conversion by oxidative phosphorylation as they harbor the respiratory chain.
In this review, we highlight the role of CL as a membrane lipid in various aspects of mitochondrial physiology. We describe the role of CL in mitochondrial morphology and its role in protein trafficking. As CL directly interacts with the respiratory chain and a number of other essential protein complexes in mitochondrial membranes, CL deficiency has a significant impact on mitochondrial metabolism and changes signalling of mitochondria in response to stress. We describe cellular and animal models for BTHS and highlight how mitochondrial dysfunction induces sarcomere disorganization and reduced contractility, resulting in dilated cardiomyopathy in vivo.
CL biosynthesis and remodelling
CL is highly abundant in cardiac tissue and was initially isolated from bovine heart. 19 CL is a phospholipid with a glycerol head group esterified with two phosphatidylglyceride backbone molecules. One CL molecule contains four fatty acids. As all four positions can be occupied by different fatty acids, a highly diversified pool of CL species is found in most mammalian tissues. 20 In contrast, an extraordinary selection process in the mammalian heart generates a defined species composition with linoleic acid (18:2) being the predominant form for all four acyl chains bound 21 It is assumed that the high energy demand in the heart facilitates the selection for the specific fatty acid composition of CL. 22 The large number of cardiac diseases connected to alterations in CL species composition demonstrate the importance of the specific CL pool for heart function (see below). [23] [24] [25] [26] [27] [28] CL is asymmetrically distributed within mitochondrial membranes. It is predominantly located in the IMM, which is comprised of up to 20% of CL. [29] [30] [31] The IMM is also the place for its synthesis ( Figure 2) . CL synthesis originates from phosphatidic acid (PA), which is imported from the ER and shuttles across the IMS by the recently discovered heterodimeric protein complex PRELID-TRIAP1. [31] [32] [33] In the mitochondrial matrix, PA is activated by the reaction with cytidine triphosphate (CTP) to form CDP-diacylglycerol (CDP-DAG) catalyzed by the CDP-DAG synthase TAMM41. 34 The committed step in CL biosynthesis is catalyzed by the phosphatidylglycerol phosphate synthase (PGS1). PGS1 uses activated PA and glycerol 3-phosphate to form phosphatidylglycerol phosphate (PGP), [35] [36] [37] which is then converted to phosphatidylglycerol (PG)
by protein-tyrosine phosphatase mitochondrial 1 (PTPMT1). 38, 39 In the last step PG is then condensed with another molecule of CDP-DAG by the cardiolipin synthase (CLS1) to form premature cardiolipin (pCL). [40] [41] [42] CLS1 is an integral IMM protein with the active site facing the matrix (see Figure 2 for the topology of the enzymes). Newly synthesized CL contains a variety, mostly saturated acyl chains. To generate the cardiac specific tetralinoleyl CL, CL is remodelled by the exchange of fatty acid moieties. Mitochondrial localized members of the Ca 2þ -independent phospholipases (iPLA 2 , iPLA 2 c, iPLA 2 -VIA, and HSD10) have been suggested to catalyze the initial deacylation of CL to form monolysocardiolipin (MLCL). [43] [44] [45] [46] [47] The subsequent reacylation to form mature CL is mediated by tafazzin, a coenzyme A independent acyltransferase. Tafazzin catalyzes the reversible transacylation of a fatty acid molecule from lecithin (phosphatidylcholine) onto MLCL forming mature CL and lysolecithin. 48, 49 Surprisingly, the substrate specificity of tafazzin was very low in vitro, and it was shown that the physical state of the lipid environment determines specificity of the tafazzin mediated reaction. [50] [51] [52] Studies of the yeast tafazzin homologue have localized the enzyme in the IMS bound to either the IMM or OMM. 53, 54 The localization of tafazzin in the IMS causes a topological problem as CL is synthesized in the matrix needs to be transported across the IMM to access its site of remodelling. The phospholipid scramblase PLS3 has been suggested to mediate this transport. 55 The gene encoding for tafazzin is mutated in BTHS, and the resulting inactivation of this enzyme causes a block in the generation of mature forms of CL. As this coincides with increased levels of MLCL, the increased ratio MLCL/CL measured in platelets, leucocytes or blood spots can be used as a diagnostic marker for BTHS. 56 Several studies have observed changes in CL amounts and species composition in heart disease. Tetralinoleyl CL and total CL levels decrease in pediatric patients diagnosed with idiopathic dilated cardiomyopathy (IDC) coinciding with a decrease in gene expression of CL biosynthesis and remodelling enzymes. 57 Many biological oxidations, in particular the respiratory chain, generate ROS as byproducts. Under physiological conditions, mitochondrial ROS plays a role as a signalling molecule in organismal homeostasis as it generates signalling responses and changes in nuclear gene expression. 58 However, under non-physiological conditions mitochondrial ROS has detrimental effects as it causes random and cumulative cellular damage. 14 In the aging heart and in common cardiac diseases, such as ischaemia/reperfusion injury and heart failure, excessive ROS production is considered causative for changes in CL levels. 26, 59 CL is susceptible to oxidation, because it is rich in unsaturated fatty acids and resides in close proximity to the sites of ROS production (see below). 22, 26 Oxidative stress has been also associated with in atrial dysfunction. For more information on the role of ROS in in atrial dysfunction see other reviews in the literature.
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Figure 2 
The role of CL in mitochondrial protein transport
Most mitochondrial proteins are nuclear encoded and are transported into mitochondria after their translation in the cytosol. Protein transport across mitochondrial membranes is mediated by specialized translocases in the inner and outer membrane. 66, 67 Translocases are located in CL rich contact sites, where inner and outer membrane converge to close proximity ( Figure 3) . The central entry gate for protein translocation into mitochondria is the translocase of outer membrane (TOM), which requires CL for its structural integrity. 30 Many proteins of the outer membrane are beta-barrel proteins, which require the Sorting and Assembly Machinery (SAM) for their integration into the outer membrane. Also the SAM complex requires CL for its stability, explaining why the transport and integration of beta barrel proteins into the OMM is strongly affected in CL deficient yeast. 30 Proteins destined to the IMM or the matrix are transported by the translocases of the IMM such as the TIM23 complex, where the Presequence Translocase associated Motorcomplex (PAM) drives the import of precursor protein. 68 Metabolite carrier proteins of the inner membrane are transported via the TIM22 translocase. The structure of TIM23 complex, its association with PAM and the integrity of the TIM22 translocase have been shown to be dependent on CL. 34, 69, 70 After import and maturation, cofactors are integrated into mitochondrial proteins, which then acquire their native conformation. Data from yeast as a model system suggest that CL also plays a role in cofactor integration, as reduced enzymatic activity of Fe-S containing proteins has been reported in CL-deficient yeast.
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The role of CL in mitochondrial morphology
Cardiomyocyte mitochondria are arranged in between myofibrillar elements and align along the long axis of the cell. 73 Mitochondrial morphology is dramatically changed when CL is deficient. Cardiac biopsy from BTHS patients show greatly enlarged mitochondria with malformed cristae structures, which form bundles of stacked membrane structures. 74 Similar changes in mitochondrial morphology has been described for many tafazzin deficient cell and animal models including yeast, BTHS patient derived lymphoblasts, Drosophila, Caenorhabditis elegans, Trypanosoma, and mouse. 11, [75] [76] [77] [78] [79] It is assumed that the exceptional biochemical properties of CL are responsible for its impact on mitochondrial morphology. Due to its unsaturated fatty acids, CL adopts a coneshaped structure. As a non-bilayer forming lipid, CL segregates into regions of locally high curvature or can even induce the formation of membrane bends. Therefore, it has been suggested that tafazzin mediated CL remodelling contributes to mitochondrial morphology and explains morphological changes in tafazzin deficient cells. 80 Large assemblies of the scaffolding protein prohibitin support segregation of CL and phosphatidylethanolamine (PE) into distinct membrane domains. [81] [82] [83] Defective cristae structures in prohibitin deficient cells revealed the impact of these membrane domains for mitochondrial morphology. 84, 85 In many cell types, the mitochondrial network is maintained by two opposing processes: fusion (merging of two mitochondria) and fission (segregation of two mitochondria). Both processes are mediated by a set of dynamin related GTPases which mediate fission (DRP1) or fusion 
(MFN1, MFN2, and OPA1). [86] [87] [88] Although fusion and fission events occur in cardiomyocytes very infrequently, fusion and fission proteins are abundantly expressed and have been found to be essential for cardiac function. [88] [89] [90] [91] [92] [93] Interestingly, binding of the IMM protein OPA1 to CL stimulates its oligomerization and its GTPase activity. 94, 95 It has been speculated that by the specific interaction to CL, OPA1 is recruited to specific sites of membrane fusion. It was also shown that CL is required for the processing of OPA1 precursors into a balanced equilibrium of isoforms. 82 A recent study showed that imbalanced OPA1 processing results in metabolic changes and induced dilated cardiomyopathy (DCM) in a mouse model. 96 Besides mitochondrial fusion, MFN2 also functions as a linker protein between the ER/SR and mitochondria, thereby controlling SR-mitochondrial Ca 2þ transmission required for energy supply-and-demand matching in cardiac myocytes, but also other cell types. [97] [98] [99] However, it is presently unclear whether CL deficiency also affects Ca 2þ uptake into mitochondria.
The mitochondrial contact site and cristae organizing system (MICOS), located at the cristae junctions, is required for the structural organization of the IMM. In the absence of MICOS, the mitochondrial network becomes fragmented and the inner membrane forms large integral membrane stacks. [100] [101] [102] [103] [104] [105] The MICOS complex consists of seven subunits, located in the IMM, and exposes their functional domains into the intermembrane space ( Figure 3) . MICOS forms multiple interactions with partners in the inner membrane, like OPA1, and the outer membrane, like the TOM and the SAM complex, in line with its role as a structural organizer. 100, [106] [107] [108] [109] Interestingly, the mammalian MICOS subunit Mic27 and the plant subunit Mic60 was shown to bind to CL in vitro.
Later it was shown that CL is necessary for the integration of the Mic27 subunit into the MICOS complex.
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Structural and functional role of CL in the respiratory chain and metabolism
The original publication by Peter G. Barth describes lower respiratory rates in isolated skeletal muscle mitochondria in BTHS patients. 113 Decreased respiration and reduced activity of single respiratory enzymes have subsequently confirmed in several models of BTHS including BTHS patient derived fibroblasts and lymphoblasts and cellular and animal models. 3, 10, 11, [114] [115] [116] The respiratory chain in the IMM consists of five complexes (complex I-V) involved in the electron transport from NADH or FADH 2 onto molecular oxygen ( Figure 3) . Electron transport is coupled with proton export across the IMM, generating a proton gradient (DpH) which, together with the electrical gradient (DW m ), constitutes the proton motive force (Dm H ). The latter is the driving force for the F 1 F o -ATP synthase to produce ATP. Complex I is the first complex in the respiratory chain and transfers electrons from NADH onto ubiquinone. The structure of complex I consisting of 45 subunits has been resolved recently and specific interaction sites for CL have been identified. 117 CL was found to be necessary for the structural integrity and full activity of complex I. 118, 119 Complex II catalyzes the electron transfer from succinate onto ubiquinone. As a constituent of the Krebs cycle, complex II (succinate dehydrogenase) is also involved in many catabolic and anabolic processes like gluconeogenesis, biosynthesis of haeme, synthesis of amino acids and fatty acids, supplying the cells with essential metabolites. CL was found to be required for the stability and optimal enzymatic activity of complex II, 120 and accordingly, the levels and activity of complex II are reduced in BTHS. 116 The crystal structure of dimeric complex III revealed several CL binding sites. 121, 122 One binding site is located at the interaction site of complex III dimer, suggesting that CL is involved in the structural integrity of complex III. A second site is located near the ubiquinone binding site, implying a role for CL in proton pumping activity. A reduced complex III activity was described in the mouse model of BTHS. 116 The cytochrome c oxidase (complex IV) also contains several binding sites for CL. As CL was found in close proximity to the opening of the putative proton pumping channel, a role for CL in proton transport has been suggested. 123 The last complex of the respiratory chain (complex V) also interacts with CL. Also here a role for CL in proton translocation has been suggested. [124] [125] [126] Respiratory chain complexes assemble into large supercomplexes, in which complex I forms a binding platform, recruiting a dimer of complex III and several copies of complex IV (Figure 3) . Supercomplex formation increases the efficiency of the electron translocation and minimizes the risk for the generation of toxic ROS. About 200 CL molecules are associated with the bovine mitochondrial supercomplex, and the presence of CL was found to be required for the structural integrity of supercomplexes. [127] [128] [129] The structural complexity of supercomplexes requires additional regulatory proteins that mediate their assembly and stability. [130] [131] [132] Recent research identified Stomatin-like protein 2 (SLP-2), a protein specifically required for the correct assembly of supercomplexes, as a CL binding protein. 133, 134 Interestingly, in BTHS mitochondria, the abundance of supercomplexes is reduced and lower molecular weight forms of the respiratory chain are strongly increased. 116, 135, 136 As supercomplexes are considered essential for efficient respiration, this remodelling partly explains the observed reduction in respiration. As inefficient electron transfer within the respiratory chain causes the generation of ROS by aberrant slippage of electrons to O 2 , forming superoxide (
elevated levels of ROS were found in BTHS. 116 As mentioned above, changes in CL levels and species composition is not unique for BTHS, but has been described in other forms of cardiac disease as well. Accumulating evidence supports the view that changes in the CL pool has structural implications in the respiratory chain supercomplexes in many forms of cardiac disease. For instance, a decreased amount of supercomplexes has been found in a model for heart failure induced by coronary microembolization in dogs. 137 ROS-induced damage of CL, reduced CL levels or alterations in its species composition is associated with many forms of cardiac disease. Changes in the CL pool have been considered to be causative to structural remodelling of the respiratory chain supercomplexes in aging, 138 ischaemia/reperfusion, 139, 140 and heart failure. 28, 141 The structural remodelling of the respiratory chain further aggravates the generation of ROS, initiating a vicious cycle of structural damage and oxidative stress. In fact, increased mitochondrial ROS have been identified as a causal factor in the development and progression of various forms of heart failure. 14, 142 Preventing ROS induced remodelling of the respiratory chain was tested as a strategy for therapeutic intervention In a ischaemia/ reperfusion model. 140 The ADP/ATP carrier (ANT) is the most abundant protein in the IMM. Two or three CL molecules per monomer have been found in the crystal structure of ANT. 143 CL molecules are also localized at the interface of two monomers, providing a potential link for dimer formation. 54, 144 ANT belongs to the large family of mitochondrial carrier proteins, which includes the phosphate carrier (PiC), the pyruvate carrier, the tricarboxylate carrier, and the carnitine/acylcarnitine translocase, required for the transport of fatty acids. carrier family share large similarities in their structure. Due to the similarities it was suspected that the structure and function of these carriers also depend on CL. 80 Cardiac metabolism is characterized by a strong dependency on fatty acid oxidation (FAO). A central regulator of FAO is the Very long-chain specific acyl-CoA dehydrogenase (VLCAD), which catalyzes the first step of the beta-oxidation of long-chain fatty acids in the heart. VLCAD is peripherally bound to the IMM. Recent data showed that a c-terminal CL binding domain is responsible for the specific interaction with the membrane. This domain was found to be a target for regulation via acetylation and succinylation by the mitochondrial deacetylase SIRT3 and desuccinylase SIRT5. These data suggest reversible lysine acylation of a CL binding protein as a novel mechanism to regulate FAO. 145 
The role of CL in cellular stress response
Cytochrome c, an IMS resident, small haemeprotein in the respiratory chain, has been found to form specific electrostatic interactions with CL. Under pathological conditions, such as ischaemia, the interaction pattern changes to a strongly hydrophobic interaction. 146 The resulting conformational changes convert cytochrome c from an electron carrier into a peroxidase, catalyzing the peroxidation of CL. 147 Cytochrome c loses its interaction with oxidized CL, which is a prerequisite of cytochrome c release during apoptosis. 148 Peroxidized CL was also found to be involved in opening of the mitochondrial permeability transition pore (MPTP). VDAC in the OMM, the adenine nucleotide transporter (ANT) in the IMM, and the peripherally associated peptidyl-prolyl cis-trans isomerase cyclophilin D are constituents of the MPTP, which forms a large pore in the inner membrane during the execution of apoptosis. Opening of the MPTP in response to Ca 2þ overload plays a critical role in cardiomyocyte cell death during ischaemia/reperfusion. 149 The association of ANT with CL (see above) provides an explanation for the finding that peroxidized CL was found to have synergistic effect with Ca 2þ in triggering the opening of the MPTP. 150, 151 During apoptosis, CL relocates to the IMM and serves as a binding platform for the recruitment of pro-apoptotic factors. CL is required for the binding of caspase 8 and pro-apoptotic Bcl-2 proteins, including BID, BAK and BAX to the OMM (Figure 4) . [152] [153] [154] Therefore, CL is also involved in outer membrane permeabilization and execution of apoptosis. CL accumulation on the OMM is also involved in mitochondrial quality control. Following cellular stress, defective mitochondria are targeted for selective removal by an autophagic process (mitophagy), preventing the accumulation of damaged proteins and organelles within a cell. 155 Mitophagy also plays an essential role during cardiac development and maintains cardiac function in the adult heart. [156] [157] [158] [159] The selective recognition of mitochondria by the autophagic machinery is mediated by specific adaptor proteins, such as LC3. The first step in autophagy is the formation of the membrane (phagophore or isolation membrane), which will expand and finally form the autophagosome. By binding to mitochondria, LC3 recruits the phagophore, specifically, to mitochondria targeted for degradation. A recent study identified a CL binding site in LC3 and found that CL accumulating on the OMM recruits LC3 and promotes the engulfment of damaged mitochondria by autophagosomes ( Figure 4) .
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The mechanism by which CL relocates from the IMM to the OMM is poorly understood. Recently, two proteins in the IMS have been identified as CL transporters. The mitochondrial creatine kinase (MtCK) is known as an important enzyme for the production of phosphocreatine, which serves as an energy buffer to maintain cellular energy homeostasis. The second protein is the nucleoside diphosphate kinase (NDPK-D/ NM23-H4), which is known to transfer the terminal phosphate group from nucleoside triphosphates to diphosphates and maintains the equilibrium between different nucleotides. Both, mtCK and NDPK are 
present as large oligomeric complexes in the intermembrane space and have been shown to interact with CL. 162 Recent studies indicate a role of these complexes in CL transfer between the inner and outer membrane ( Figure 4) .
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Models of BTHS
Cellular models for BTHS, including patient-derived fibroblasts, lymphoblasts, neutrophils, neonatal ventricular fibroblasts, and cardiomyocytes have been studied to reveal the morphological changes of mitochondria, the structural remodelling of the respiratory chain, the decrease in respiratory capacity and an increase in the production of ROS. 3, 115, 165, 166 One of the early animal models of BTHS was the knockdown of tafazzin in zebrafish, which revealed a role of tafazzin in cardiac development causing growth retardation, bradycardia and other signs that resemble BTHS. 167 Deletion of tafazzin in Drosophila does not affect cardiac function but is characterized by male sterility and reduced locomotor activity. The reduced locomotor activity in Drosophila reflects muscle weakness and exercise fatigue akin to BTHS patients. 75, 168 In a mouse model, tafazzin gene expression was systemically reduced by 80-90% using doxycycline-induced, siRNA-mediated knock-down. 10, 11 Inhibition of tafazzin gene expression resulted in enhanced MLCL/CL ratios, similar to what has been observed in patients. Metabolic rates of resting animals were not changed, however, a severe deficiency in oxygen consumption during exercise was observed. 169 Cardiac defects including reduction in isometric contractile strength and a decrease in cardiac left ventricular (LV) ejection fraction becomes apparent after 7-8 months of age. Cardiac mitochondria were significantly enlarged and aggregated, resulting in a displacement of neighboring myofibrils. 10, 11 Disrupted cristae structures were found in skeletal and cardiac muscle. 10 Using a more stringent protocol to induce the tafazzin knock-down (higher doses of inductor to induce expression of TAZ specific shRNA) revealed a role of tafazzin in heart development in mice as was reported before in zebrafish. These animals died in utero between E12.5 and E14.5 or did not survive the newborn stage. Foetal hearts revealed myocardial thinning, defective ventricular septation, LV hypertrabeculation, and non-compaction as well as diastolic dysfunction. 170 In order to generate a human cellular model of BTHS, somatic cells from BTHS patients were used to generate induced pluripotent stem cells (iPSC), with the capacity for self-renewal and differentiation. These cell models show a shift in the CL pool, reflecting the situation in BTHS patients. Further investigation of the iPSCs revealed that remodelling of the respiratory chain supercomplexes caused a decreased respiration and an increased generation of ROS. 136 These defects were also observed in cardiomyocytes, generated by directed differentiation of pluripotent stem cells. 116, 171 Interestingly, when cardiomyocytes derived from BTHS iPSCs were seeded on micropatterned fibronectin rectangles, a significant abnormality in sarcomere organization was observed, which showed an irregular and sparse sarcomere organization. Hearton-chip assays revealed a reduced contractility for BTHS patient cardiomyocytes. 171, 172 These data showed that induced stem cell derived cardiomyocytes recapitulated well myopathic phenotypes. Interestingly, these effects were reversed using antioxidant treatment, which suggests a causative role of ROS for sarcomere disorganization and decreased force generation. This observation is in line with earlier studies revealing a role of ROS in cardiomyocyte differentiation, 173, 174 and that ROS causes structural modifications of the sarcomere, which can impact pump function. 175 
Therapeutic strategies in BTHS
The progressive understanding of the molecular mechanism of the cardiomyopathy in BTHS has fostered the development of novel therapeutic strategies. Tafazzin deficient animal models have been used to explore a novel therapeutic approach to rescue the CL pool by blocking the CL phosholipase activity. The CL phosholipase is the first enzyme in CL remodelling and converts premature CL into MLCL ( Figure 2 ). Blocking this enzyme will stop the remodelling of premature CL before its turnover to form MLCL ( Figure 5 ). This strategy prevents MLCL accumulation in tafazzin deficient cells and establishes a pool of premature CL, which differs from mature species in a higher content of saturated fatty acids ( Figure 5) . In a tafazzin deficient Drosophila strain, genetic inactivation of phospholipase A 2 increased CL levels and reverted the male sterility phenotype. Also Figure 5 Therapeutic strategies in BTHS. Therapeutic strategies, which have been evaluated in experimental models of BTHS include bromoenol lactone (BEL), an inhibitor of phospholipase A 2 (iPLA 2 ), the Schiller Szeto peptide (SS31), which is physically interacting with CL, and the mitochondria targeted antioxidant mitoTEMPO. OMM, outer membrane; IMM inner membrane; IMS, intermembrane space. 46 However, inactivation of iPLA2c function in BTHS mice did not prevent the decrease in tetralinoleyl CL found in the TAZ knockdown mice, suggesting that iPLA2c is not involved in CL remodelling in the mammalian heart. 176 Linoleic acid is a precursor molecule for CL and its administration to fibroblasts from BTHS patients reestablished CL levels in a dose dependent manner. 177 In patient derived cardiomyocytes, linoleic acid rescued the sarcomere structure. 171 These studies raised the question whether linoleic acid integration into CL or its antioxidant activity were responsible for the beneficial effect. In fact, targeting the antioxidant MitoTEMPO to mitochondria induced a reorganization of sarcomeres and rescued the function of cardiac myocytes. 171 Another possible approach is the use of the Szeto-Schiller peptide (SS-31), a tetrapeptide that accumulates 1000-fold in mitochondria (independent of DW m ) due to its high affinity to CL through hydrophobic and electrostatic interactions. 178 These peptides have been shown to inhibit CL-induced cytochrome c peroxidase activity, to protect mitochondrial morphology and to promote oxidative phosphorylation. 178 ,179 SS-31 is already in clinical testing in patients with cardiovascular diseases. In patients with acute myocardial infarction, it was safe and well tolerated, but failed to reduce infarct size after a single shot intracoronary application before reperfusion of ischaemic myocardium (EMBRACE-STEMI). 180 Nevertheless, based on positive preclinical results in various heart failure models, 142, 178, 181 the drug is currently under clinical investigation in patients with systolic and diastolic heart failure (NCT02814097; NCT02914665; NCT02788747). Given its specificity to CL as its mode of action, it will be interesting whether this class of drugs is also useful in patients with BTHS.
Conclusions
Mitochondria play an essential role in cardiac metabolism, and many essential functions were shown to be dependent on CL. Studies on BTHS have helped to understand the role of CL in mitochondrial protein transport, shaping mitochondrial morphology and also for mitochondrial biogenesis -as reviewed in more detail previously. 182 CL is an integral component of the respiratory chain supercomplexes, and CL deficiency causes a decrease in respiratory capacity and an increase in ROS production. The tight interaction between CL and supercomplexes has also implications on CL itself. When compared with other phospholipids, CL was found to have an extraordinary long half-life. [183] [184] [185] Recent data indicate that the slow turnover of CL is due to its ability to bind to the respiratory chain. 186 When this association is lost, CL may become more susceptible to degradation, which may contribute to low CL levels in BTHS. Moreover, it was speculated that stress situations may cause a remodelling of the respiratory chain. This remodelling liberates CL from its close interaction with respiratory chain complexes, which makes it more prone to degradation. This effect might make BTHS patients more susceptible to clinical complications. 187, 188 
